NEW YORK (GenomeWeb) – UK prenatal diagnostics company Premaitha Health has received a £1.2 million ($3 million) loan from Thermo Fisher Scientific to cover legal costs related to its ongoing patent litigation with Illumina, the company said today.
Premaitha and Thermo Fisher entered into a secured loan facility agreement, which is secured on the shares of Premaitha's Taiwanese subsidiary, Yourgene Bioscience.